Tytuł artykułu
Autorzy
Identyfikatory
Warianty tytułu
Konferencja
21st Conference on Isoprenoids, 23-29 September 2005, Białystok-Białowieża, Poland
Języki publikacji
Abstrakty
Ent-steroids, the enantiomers of naturally-occurring steroids, are useful tools for distinguishing between receptor and non-receptor mediated actions of steroids. In particular, ent-steroids are useful for evaluating the relative importance of the direct (receptor binding) and indirect (membrane perturbation) effects of steroids on the function of membrane- bound proteins. A distinction between these two processes can be made on the basis of the different degrees of enantioselectivity expected for the two types of steroid actions. Receptor binding of steroids is expected to be enantioselective, whereas steroid effects on membrane properties are not. The synthesis of ent-steroids and examples of their use in biological studies are presented.
Słowa kluczowe
Wydawca
Czasopismo
Rocznik
Tom
Strony
511--522
Opis fizyczny
Bibliogr. 31 poz.
Twórcy
autor
- Department of Molecular Biology and Pharmacology, 660 S. Euclid Ave, Campus Box 8103, Washington University School of Medicine, St. Louis, Missouri, 63110, USA
Bibliografia
- l. Biellmann J.-F., Chem. Rev., 103, 2019 (2003).
- 2. Moss G.P., Eur. J. Biochem., 186, 429 (1989); http://www.chem.qmul.ac.uk/iupac/steroid/.
- 3. Westover EJ. and Covey D.F., J. Membrane Biol, 202, 61 (2004).
- 4. Teerhuis N.M., Huisman A.M. and Groen M.B., Tetrahedron Lett., 42, 2869 (2001).
- 5. Hajos Z.G. and Parrish D.R., J. Org. Chem., 39, 1615 (1974).
- 6. Micheli R.A., Hajos Z.G., Cohen N., Parrish D.R., Portland L.A., Sciamanna W., Scott M.A. And Wehrli P.A., J. Org. Chem., 40, 675 (1975).
- 7. Hajos Z.G. and Parrish D.R, J. Org. Chem., 38, 3239 (1973).
- 8. Ohloff G., Maurer B., Winter B. and Giersch W., Helv. Chim. Acta, 66, 192 (1983).
- 9. Larson G.L. and Klesse R., J. Org. Chem., 50, 3627 (1985).
- 10. Zoretic P.A., Yu B.-C., Biggers M.S. and Caspar M.L., J. Org. Chem., 55, 3954 (1990).
- 11. Rychnovsky S.D. and Mickus D.E., J. Org. Chem., 57, 2732 (1992).
- 12. Green P.S., Yang S.-H., Nilsson K.R., Kumar A.S., Covey D.F. and Simpkins J.W., Endocrinology, 142, 400(2001).
- 13. Crossley R., Chiraliry and the Biological Activiry of Drugs, CRC Press, Boca Raton, 1995.
- 14. Mesecar A.D. and Koshland D.E., Jr., Nature, 403, 614 (2000).
- 15. Marshall R.J., Mclndewar L, Peters J.A.M., van Vliet N.P. and Zeelen F.J., Eur. J. Med. Chem., 19, 43 ' (1984).
- 16. Zitzer A., Westover EJ., Covey D.F. and Palmer.M., FEBS Lett., 553, 229 (2003).
- 17. Ikigai H., Akatsuka A., TsujiyamaH.,Nakae T. and ShimamuraT.,Infect. Immunity, 64,1968 (1996).
- 18. Bhakdi S., Tranum-Jensen J. and Sziegoleit A., Infect. Immunity, 47, 52 (1985).
- 19. Belelli D. and Lambert J J., Nature Rev. NeuroscL, 6, 565 (2005).
- 20. Wittmer L.L., Hu Y., Kalkbrenner M., Evers A.S., Zorumski C.F. and Covey D.F., Mol. Pharmacol,50, 1581 (1996).
- 21. Hu Y, Wittmer L.L., Kalkbrenner M., Evers A.S., Zorumski C.F. and Covey D.F., J. Chem. Soc.,Perkin Trans., 1, 3665 (1997).
- 22. Covey D.F., Nathan D., Kalkbrenner M., Nilsson K.R., Hu Y, Zorumski C.F. and Evers A.S., J.Pharmacol. Exp. Ther., 293, 1009 (2000).
- 23. Nilsson K;R., Zorumski C.F. and Covey D.F., J. Med. Chem., 41, 2604 (1998).
- 24. Behl C., Subcell. Biochem., 38, 65 (2005).
- 25. Simpkins J.W., Yang S.H., Wen Y. and Singh M., Cell. Mol. Life Sci., 62, 271 (2005).
- 26. Perez E., Liu R., Yang S.H., Cai Z.Y., Covey D.F. and Simpkins J.W., Brain Res., 1038, 216 (2005).
- 27. Simpkins J.W., Wen Y, Perez E., Yang S. and Wang X., Ann. N.Y. Acad. Sci., 1052, 233 (2005).
- 28. Kurzchalia T.V. and Ward S., Nat. Cell. Bio., 5, 684 (2003).
- 29. Hieb W.F. and Rothstein M., Science, 160, 778 (1968).
- 30. Chirwood D.J., Crit. Rev. Biochem. Mol. Biol, 34, 273 (1999).
- 31. Crowder C.M., Westover EJ., Kumar A.S., Ostlund R.E., Jr. and Covey D.F., J.. Biol. Chem., 276, 44369(2001).
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-article-BUJ3-0006-0050